Welcome to our dedicated page for Kimball Electronics news (Ticker: $KE), a resource for investors and traders seeking the latest updates and insights on Kimball Electronics stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kimball Electronics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kimball Electronics's position in the market.
Kimball Electronics, Inc. (Nasdaq: KE) will participate in various investor conferences in May 2024. The company will attend the Oppenheimer 19th Annual Industrial Growth Conference, EF Hutton Annual Global Conference, and B. Riley Securities 24th Annual Institutional Investor Conference. Kimball Electronics is a global provider of electronics manufacturing services with operations in multiple countries. The company values quality, reliability, speed, and ethical behavior.
Kimball Electronics, Inc. (Nasdaq: KE) reported Q3 results with $425.0 million in net sales and a net loss of $6.1 million, including impairment costs related to the Automation, Test & Measurement business. The company expects to divest this segment. Adjusted net income was $8.4 million, and adjusted operating income was $17.0 million. The company is focusing on EMS operations, aligning costs with demand trends, and reducing capital expenditures. Share repurchases have resumed. Guidance for fiscal 2024 includes a 4-6% decline in net sales and adjusted operating income of 4.2-4.6% of net sales.